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Abstract.  In vitro binding studies with isolated bovine 
lens vimentin and avian erythrocyte membranes reveal 
the existence of two functionally distinct sets of inter- 
mediate filament attachment sites.  One population of 
such receptors is located along the nuclear envelope 
and comprises polypeptides recognizing the carboxy- 
terminal tail domain of vimentin. Vimentin associates 
with these nuclear surface receptors in a  cooperative 
manner and forms extensive 10-nm filaments in a 
concentration-dependent fashion. Conversely, the 
plasma membrane contains binding sites that interact 
in a noncooperative, saturable fashion with vimentin, 
recognizing its amino-terminal head domain.  The 
functional dichotomy of the vimentin-binding sites un- 
der in vitro conditions may reflect a  vectorial assem- 
bly process whereby 10-rim filaments, although struc- 
turally apolar,  acquire polar features brought about by 
the differential attachment to specific receptors ar- 
ranged along the plasma membrane and the nuclear 
envelope. 
UE tO the complexity of the subplasmalemmal region 
of eukaryotic cells,  where  numerous  cytoskeletal 
elements converge or anastomose, only a few model 
systems have been used so far for studying the association 
of filaments with membranes (lens, erythrocytes, etc.) (14, 
27). Within these boundaries we have recently analyzed the 
molecular  interactions  of the  intermediate filament (IF) ~ 
subunit  vimentin  with  the  plasma  membrane  using  the 
anucleate human erythrocyte as a model system and using 
several  quantitative criteria  to  assess  the  specificities in- 
volved. In this manner, the polypeptide ankyrin (or band 
2.1),  a major component of the so-called membrane skele- 
ton, was characterized as a high-affinity vimentin acceptor 
(11). The binding was found to be highly site-specific.  The 
associating regions comprised the amino-terminal head do- 
main of vimentin and a segment on ankyrin adjacent to, but 
distinct from, the spectrin-binding site,  which is also con- 
tained in the same 55-60-kD domain of this molecule (12, 
13; Weaver,  D.,  and S.  Georgatos, manuscript in prepara- 
tion).  In  vitro  polymerization  studies  revealed  that  the 
binding of isolated ankyrin to vimentin oligomers prevents 
the formation of IFs, which are otherwise assembled from 
purified subunits under similar solution conditions (12). The 
latter observation, together with other data that show a de- 
pendence of the binding on the concentration of polymer 
ends, as well as its saturable and noncooperative character, 
led us to the conclusion that the plasma membrane provides 
exclusively termination attachment sites for IF and that the 
putative centers from which IF assembly is initiated should 
1. Abbreviation  used in this paper:  IF,  intermediate filament. 
reside in a different cellular domain. The nuclear envelope 
seemed a reasonable candidate for such a nucleation func- 
tion. We therefore sought to develop an in vitro assay where- 
by the binding of purified IF subunits to plasma and nuclear 
membranes of the same cell could be accurately measured 
and meaningfully compared. Here, the results of this effort 
are reported, showing that vimentin filaments can only be as- 
sembled from nuclear envelope-associated sites, which are 
distinct from their plasma membrane counterparts in func- 
tion and specificity. 
Materials and Methods 
Nuclear Envelope Isolation 
71)--80 ml  of blood  was  collected from the wing veins of turkeys  into 
heparinized tubes. The blood was briefly centrifuged to separate the plasma 
from the formed elements (~1,000 g, 10 min, 40C). The "buffy coat" (con- 
taining white blood cells and platelets) was removed by aspiration. The re- 
maining red cells were washed with a total of 300 rnl of PBS (150 mM NaC1, 
10 mM NaPO4,  pH 7.4) at 0°C. To osmotically disrupt the erythrocytes, 
360 rod of lysis buffer (5 mM NaPO4, 2 mM MgCI2, 2 mM I~-mercaptoeth- 
anol, 1 mM phenylmethylsulfonyl fluoride (PMSF), pH 7.6) was added to 
,~25 ml of packed cells. The suspension was stirred on ice for 15 rain. 
The resulting nucleated erythrocyte ghosts were harvested by centrifuga- 
tion (16,000 g,  1 min, 4°C), The leukocy~ button was discarded, and the 
ghosts were resuspended at a hematocrit of 10% in fresh lysis buffer.  10-ml 
aliquots of this suspension were sonicatexi (Sonifier Cell Disruptor 100, set- 
ting of 3, meter reading 50-60; Branson Sonic Power Co., Danbury, CT) 
at 0°C for 15-20 s in a  conical corex tube. Enucleation was checked by 
phase-contrast microscopy. The preparation was centrifuged (,'~1,500 g, 5 
min, 4°C) to separate the nuclei from plasma membranes. The upper two- 
thirds of  the supernatant was collected and kept for plasma membrane isola- 
tion. The pellet (nuclei) was resuspended in 15 ml oflysis buffer and passed 
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taminants and debris adhering to the nuclei. The nuclear suspension was 
centrifuged as above and the pellet was washed once with 25 ml of lysis 
buffer.  Finally,  the washed nuclei were resuspended in 10 ml of the same 
media and divided into two 5-ml aliquots. 
To each aliquot, 250 lxl of DNase I (2 mg/ml in PBS-I mM PMSF), 25 
txl of 1 M MgCI2, and 500 ~tl of 10×  PBS were added sequentially under 
vortexing. After an incubation (15 rain, room temperature), the preparation 
was centrifuged through a cushion of 10% sucrose (5 ml in PBS at 12,000 
g for 10 min and at 40C). Digestion with the nuclease was repeated once 
more in exactly the same manner. The pellet was resuspended in 35 nil of 
PBS-1 mM PMSF and centrifuged as above yielding nuclear envelopes. Part 
of the preparation was kept in PBS-2 mM MgC12, 0.5 mM PMSF pH 7.6 
at 0°C. The rest was processed further (see below). 
Plasma Membrane Isolation 
The first postnuclear supernate was passed three times through a 23-gauge 
syringe needle (as above) and centrifuged (2,000 g, 15 min, 4°C) to pellet 
any remaining nuclei. The upper two-thirds of the supernatant were aspi- 
rated with a syringe and sedimented at 16,000 g for 30 s at 4°C. The pellet 
was discarded, while the supernatant was further centrifuged (16,000 g, 30 
min, 4°C). The top, whitish layer was gently detached from the rest of the 
redish pellet by turning the tube and was resuspended in 35 ml of 5 mM 
NaPO4,  1 mM EDTA, 2 mM 2-mercaptoethanol, 0.5 mM PMSF, pH 7.6. 
The membranes were re-pelleted yielding plasma membranes. Part of the 
preparation was kept in 5 mM NaPO4, 0.5 mM PMSF, pH 7.6 at 0°C. The 
rest was processed further (see below). 
Extraction of  Endogenous Vimentin from Plasma 
and Nuclear Membranes 
Nuclear envelopes or plasma membranes (see above) were resuspended in 
30-40 vol of 5-10 mM NaPO,, 0.5 mM PMSF, pH 7.6 or alternatively, in 
glass-distilled water.  The preparations were vigorously vortexed tbr 10-15 
s and then centrifuged at  16,000 g  for 30 min at 4°C.  The pellets were 
resuspended in the same media and stirred overnight (12-18 h) at 0°C. After 
pelleting as above, the membranes were washed once in PBS (nuclear enve- 
lopes) or 5 mM NaPO4  (plasma membranes) and finally resuspended in 
PBS-2 mM MgCI2-0.5  mM PMSF pH 7.6 or 5  mM NaPO4,  0.5  mM 
PMSF pH 7.6. They were kept on ice for a maximum of 5 d. 
Purification of Vimentin 
Vimentin was purified from calf lens essentially as previously described (12) 
with the following modifications:  (a)  The  (NH4)2SO,  precipitation step 
was eliminated from the protocol, and (b) ion-exchange chromatography 
was carried out with 10 mM NaPO4,  1 mM EDTA, 5 mM I~-mereapto- 
ethanol, 0.2 mM PMSF, and 8 M urea, pH 7.4 as a basal buffer and at room 
temperature. Elution was achieved with a 0-200 mM NaC1 gradient. 
lodination of Vimentin 
Purified vimentin was iodinated by the ~251-Bolton-Hunter reagent (2,000 
Ci/mmol) as specified previously (12). 
Digestion of  Membranes with Proteolytic  Enzymes 
Plasma membranes or nuclear envelopes were washed with PBS and then 
incubated with trypsin (enzyme/protein ratio 1:80) for 20 rain at 0°C. The 
reaction was stopped by adding PMSF (to  1.3 mM). The digested mem- 
branes were extensively washed with PBS-1 mM PMSF and used for assays. 
No  protease  activity  was  detectable  in  these  preparations  upon  co- 
incubation with ~:SI-vimentin. 
Digestion of  Nuclear Envelopes with Nucleases 
Vimentin-depleted nuclear envelopes (2.5 mg/ml) were digested at room 
temperature with a mixture of DNase I and RNase A each at a concentration 
of 0.15 mg/ml for 20 rain. The envelopes were pelleted (12,000 g, 30 rain) 
and washed three times with PBS, 2 mM MgCI2,  0.5 mM PMSF pH 7.6 
before assaying. 
Chymotryptic Cleavage  of Vimentin 
125I-Vimentin was dialyzed against 5  mM NaPO4  pH 7.6 (4°C) and then 
digested with a-chymotrypsin exactly as described by Geisler et al.  (9). 
Digestion was stopped by PMSF (to 1.3 raM), cooling on ice, and adjust- 
ment of salt to isotonic by the addition of 10x PBS. The digests remained 
stable for at least 1 wk on ice. 
Antibodies 
Immunoblotting data presented in this paper were produced by an anti- 
vimentin antibody (polyclonal)  recognizing both avian and  mammalian 
vimentin (provided by Dr. E. ~-ag, The Rockefeller University). The charac- 
terization of the anti-ankyrin antibody has been described previously (11). 
Binding Assays 
125I-Vimentin (at  a  specific activity  of 200,000  cpm/llg)  and  in  2  mM 
NaPO4, 0.1 mM PMSF pH 7.6 was combined with 40 txg of plasma mem- 
branes or 70  Ixg of nuclear envelopes. The salt was adjusted to  150 mM 
NaCI, 10 mM NaPO4, 0,3 mM MgC12, 0.1 mM PMSF pH 7.6 and the final 
volume to 120-150 ~tl. BSA was included in the assay mixture (at a concen- 
tration of  0.1 mg/ml) to prevent nonspecific  adsorption to the plastic. Incuba- 
tions were for 50 rain (nuclear envelopes) and for 90 rain (plasma mem- 
branes). After that, the reaction mixtures were transferred to 400-1xl hard 
polyethylene tubes over a  120-~tl cushion of isotonic (4%) sucrose with an 
air bubble in-between. Bound t~I-vimentin was separated from nonbound 
by sedimentation at 12,000 g for 28 rain at 4°C. The tubes were immediately 
frozen in liquid N2 and dissected with a razor blade. The pellet-containing 
tips and the rest of the tube were then counted for radioactivity. Prestan- 
dardization of the pelleting system showed that 99.3 % of the membranes are 
pelleted under these conditions, while <0.3% of the mI-vimentin is sedi- 
mented in the absence of membranes. For each binding curve individual 
points were averages of at least four independent observations. The variation 
was always <10%. 
Immunoblotting 
Proteins, separated by SDS-PAGE, were electrophoretically transferred to 
nitrocellulose sheets. The blots were processed exactly as described by 
Granger and Lazarides (16) with 0.1% gelatin as a blocking and carrier pro- 
tein.  Antibody dilutions were 1:100 for anti-ankyrin and  1:200  for anti- 
vimentin. Staphylococcus aureus protein A-tZ~I was applied to 0.3 ~tCi/ml 
at a specific activity of 10 ~tCi/Ixg. 
Electrophoresis 
Electrophoresis was according to Laemmli (21). 
Protein Determinations 
Protein concentrations were estimated according to Lowry (23)  with BSA 
as a standard. The protein content of individual gel bands (that had been 
stained by Coomassie Brilliant Blue) was estimated after an overnight ex- 
traction with pyridine (6).  BSA was used as a standard. 
DNA Determinations 
The DNA content of  the membranes was estimated according to Ceriotti (5) 
using salmon sperm DNA as a standard. 
Electron Microscopy 
Samples were applied to formwar-coated, glow-discharged, 300-mesh grids 
for 1 rain at room temperature. Excess liquid was removed by capillary ac- 
tion, and the grids were washed with a few drops of isotonic NaC1 buffer. 
Samples were then negatively stained with 1% uranyl acetate (15-50 s, room 
temperature), air-dried, and visualized in a Philips 300 electron microscope 
operated at 80 kV. 
Results 
Assay System 
To compare  the binding  of vimentin  with  nuclear  versus 
plasma membranes, the avian erythrocyte was chosen as a 
model system. This cell provides an excellent source of nu- 
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of  cytoplasmic contaminants. In its mature form the avian red 
cell contains a limited number of cytoplasmic organelles (4). 
More importantly, its cytoskeletal elements are well segre- 
gated:  the microtubules are localized beneath  the plasma 
membrane as a marginal disc, all actin microfilaments are se- 
questered in the subplasmalemmal membrane skeleton, while 
the IFs  extend from the  nuclear periphery to  the plasma 
membrane, away from the marginal disc (14, 15, 22,  36). 
The method of Beam et al. (2) was used to obtain nuclear 
envelope and plasma membrane fractions. This technique in- 
volves controlled sonication of osmotically disrupted  red 
ceils (ghosts) in low salt and Mg~--containing media. Fur- 
thermore, a combination of established methods (hydraulic 
shearing through bent syringe needles and differential cen- 
trifugation) was used to effectively separate the membranes 
from  cross-contaminants.  For  the  preparation  of nuclear 
envelopes, isolated nuclei were routinely treated with DNase 
I,  which  digested the bulk of the  DNA.  The  SDS-PAGE 
profiles depicted in Fig.  1 a  show the polypeptide composi- 
tion of the two membrane fractions. The plasma membrane 
fraction contained the characteristic polypeptides ankyrin, 
spectrin, band 3, actin, etc. and was free of histones or lam- 
ins.  Conversely, the nuclear envelope preparation included 
the lamins and some residual histones. The nuclear lamina 
of birds comprises basically two proteins corresponding to 
mammalian lamin A  and B  (20,  30),  as indicated by two- 
dimensional  peptide  mapping  (data  not  shown).  A  third 
band, with a molecular mass similar to rat liver lamin C, is 
in fact not a lamin but possesses features of an integral mem- 
brane constituent (see companion paper). Small quantifies of 
residual spectrin contaminated the nuclear fractions, as re- 
ported by Jackson (18). This material could not be removed by 
density gradient sedimentation or washings. However, cross- 
contamination with ankyrin (if  any) was minimal, since none 
of it could be detected by immunoblotting (Fig. 4 a). 
Most of the endogenous IFs were removed from the mem- 
brane preparations by severing the filaments during sonica- 
tion. Nevertheless, the nuclear envelopes contained "o4 ~tg 
of vimentin per mg of total protein and the plasma mem- 
branes ,o0.5 lxg of vimentin per mg of total protein (as esti- 
mated by dye extraction of Coomassie Blue-stained gels) 
Figure L  (a) Fractionation of 
turkey erythrocyte  membranes. 
SDS-PAGE profiles. Lane 1, a 
sample of  purified lens vimen- 
tin shown here as a reference 
marker; lane 2, plasma mem- 
branes before low-salt (phos- 
phate) extraction; lane 3, plas- 
ma  membranes  after extrac- 
tion; lane 4, nuclear envelopes 
before extraction; lane 5, nu- 
clear envelopes  after extraction 
(10% acrylamide  gel  stained 
with Coomassie Blue). Small 
arrows show (from top to bot- 
tom) the positions of ankyrin, 
a-spectrin, ~spectrin, and ac- 
tin.  Dashes point to the his- 
tones, and filled arrowheads to 
the avian lamin A (upper hand) 
and  lamin  B  (lower  band). 
Open arrowhead indicates the 
endogenous  avian  RBC vimen- 
tin.  (b)  Removal of endoge- 
nous  vimentin  from  turkey 
membranes as detected by im- 
munoblotting  with anti-vimen- 
tin  antibodies  (an  autoradio- 
gram is shown). Lane 1, whole 
turkey  RBC  ghosts; lane  2, 
phosphate-extracted  plasma 
membranes; lane 3, phosphate- 
extracted  nuclear  envelopes; 
lane  4,  combined  phosphate 
extracts (10 times concentrat- 
ed). The lower band (,~40 kD) 
represents a breakdown prod- 
uct of vimentin,  usually  de- 
tected upon prolonged handling of the preparation. The lower panel shows immunoblotting data of phosphate-extracted nuclear envelopes 
(lane 1, 70 lxg of protein) and 50 (lane 2), 100 (lane 3), 200 (lane 4), and 400 ng (lane 5) of purified vimentin using an anti-vimentin 
antibody. (c) Status of the lens vimentin used in the study. (Lef?)  An autoradiogram of purified ~SI-vimentin. (Right) An image of 10-rim 
filaments reconstituted from purified vimentin as seen after negative staining with 1% uranyl acetate (vimentin conc. ----600 ~tg/ml). For 
details see Materials and Methods. 
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washing both membrane fractions in low ionic strength phos- 
phate buffers without divalent cations. As shown in Fig. 1 b, 
no endogenous vimentin can be detected by immunoblotting 
assays with an anti-vimentin antibody that would readily de- 
tect nanogram amounts of the corresponding antigen. The 
specific effect of phosphate ions on the solubility of IFs has 
been noted by others (I, 28, 37). 
To probe  the binding of IF subunits to the erythrocyte 
membranes,  we used bovine lens vimentin (see Materials 
and Methods). The mammalian form of vimentin is structur- 
ally almost identical to the avian vimentin (26, 35, 38) and 
can be easily purified in mass quantities and in a polymeriza- 
tion-competent form (Fig.  1 c). Moreover, its polymerization 
and sedimentation properties have been explored in our pre- 
vious in vitro studies (12), which indicated that, up to 100 ~tg/ 
ml, this material exists predominantly as a soluble species 
(~85%) with a sedimentation coefficient of 6.75. At higher 
concentrations the amount of soluble vimentin decreases. 
Recent studies have established that the soluble vimentin 
form represents a tetramer (31). Such an interpretation has 
been confirmed in a series of cross-linking experiments we 
have done using the agent dimethyl suberimidate (Georgatos, 
S., unpublished results). 
Vimentin Attachment Sites at the Plasma Membrane 
When tESI-labeled vimentin was incubated with erythrocyte 
plasma membranes, a hyperbolic binding isotherm was ob- 
tained (Fig. 2 C). The shape of the curve indicated a satura- 
ble association. When equivalent amounts of washed, intact 
erythrocytes were substituted for the plasma membranes, 
much less binding was observed, strongly suggesting that the 
vimentin-membrane interaction observed in vitro was re- 
stricted to the cytoplasmic face of the membrane and there- 
fore  was  physiologically meaningful.  The  proteinaceous 
nature of the plasma membrane-binding sites was demon- 
strated by showing that trypsinized membranes were unable 
to bind vimentin (Fig. 2 C). 
Electron microscopic visualization of plasma membranes 
reconstituted with purified vimentin (at 400 lag/ml) revealed 
no apparent filament formation onto the membranes (Fig. 3 
c), a finding compatible with the saturable character of the 
binding isotherm presented above. By Scatchard plotting of 
the data (Fig. 2 D) (29), two vimentin binding site classes 
were evident: a high-affinity site (Ka "8  x  106 M-') and a 
low-affinity site (Ka ~6.2  ×  105 M-~). By Hill analysis (17), 
a coefficient of 1.02 was estimated, indicating the absence of 
cooperativity. Similar studies with the human erythrocyte 
membrane (11) had yielded only a single vimentin-binding 
site. 
Antibodies raised against human erythrocyte ankyrin have 
the potential of completely blocking the binding of vimentin 
to human inside-out RBC vesicles (11). The same reagents 
could suppress the binding of uSI-vimentin to turkey RBC 
plasma membranes by 40%  (Fig. 4 b).  These results spe- 
cifically implicate avian ankyrin in the binding process. The 
occurrence of an alternative vimentin-binding site (as indi- 
cated by the Scatchard plot) or some known differences be- 
tween avian and human ankyrin (expressed in its Mr, or in 
solubility properties) (2, 24) may account for the difference 
in the neutralizing effect of anti-ankyrin observed in the 
avian membranes. 
Vimentin Attachment Sites at the Nuclear Envelope 
Assaying of the binding of 125I-vimentin to the nuclear enve- 
lopes revealed several unique features. The isotherm in this 
case possessed an initial sigmoidal leg, indicating the occur- 
rence of positive cooperativity during the binding, a pseudo- 
plateau region and, finally, a  linear ascending segment at 
higher  concentrations  of the  radiolabeled  ligand  (Fig.  2 
A).  These characteristics of the curve suggested an initial 
trend towards saturation followed by a clearly nonsaturable 
binding. 
To investigate the origin and the physical meaning of the 
unsaturable component of the binding, various assay samples 
were examined by electron microscopy. When nuclear enve- 
lopes depleted of endogenous vimentin were analyzed, nu- 
clear ghost-like structures were observed (Fig. 3, a and b). 
These membranes lacked any 10-nm filaments, as expected 
from the immunoblotting data shown previously (Fig.  1 b). 
However, upon addition of 150 Ixg/ml of vimentin, short 10- 
nm rods were seen to decorate the surfaces of the envelopes 
(Fig. 3 d, inset). At higher magnification the rods consisted 
of thinner 2-3-nm fibrils (Fig. 3 d, arrowheads). Similar un- 
raveled filament morphologies have been noticed in keratin 
IF by other investigators and are believed to reflect the inher- 
ent protofibrillar substructure of assembled IF units (1). 
When more vimentin (200  ~tg/ml) was added to the nu- 
clear envelopes, an increase of the filament length was no- 
ticed (Fig. 3 e). Finally, upon reconstitution with 400 Ixg/ml 
of vimentin, extended IF arrays were formed (Fig. 3, f  and 
g). Thus, the nuclear envelopes were able to initiate the for- 
mation of 10-nm filaments, whereas the plasma membranes 
were not. 
Scatchard plotting of the binding data (Fig. 2 B) generated 
a convex curve with a maximum at ~80 Ixg of t25I-vimentin 
bound per mg of envelope protein. This configuration of the 
plot is  a  hallmark of positive cooperativity that was also 
deduced by Hill analysis (Hill coefficient --2.00). The bind- 
ing was salt- and time-dependent. Equilibration was reached 
after ~50 min at room temperature (24°C, Fig. 5 a). At low 
salt (below  10 mM), only negligible amounts of vimentin as- 
sociated with the nuclear envelopes, while a maximum bind- 
ing was noted at 80-130  mM of NaCI (Fig. 5 b). 
The proteinaceous nature of the vimentin-binding sites, as 
well as the specificity of the process, was demonstrated by 
showing that trypsinized nuclear envelopes cannot bind the 
radioactive tracer (Fig. 2 A). Digestion with nucleases (Table 
I) or anti-ankyrin antibodies (see companion article) did not 
affect the binding of vimentin to nuclear envelopes. After 
heat treatment (65°C, 2 min) the binding of mI-vimentin to 
nuclear envelopes was basically unchanged, while the bind- 
ing to the plasma membranes was significantly lowered but 
not abolished (Table I). Finally, acetic acid, at 0.17 M, could 
extract or neutralize all the vimentin-binding activity of both 
nuclear and plasma membranes (Table I). 
Mechanism of  Nuclear Attachment 
There are, conceivably, two ways to explain the observed as- 
sembly of 10-nm filaments on the nuclear envelopes: Fila- 
ments may first assemble in solution and then bind as such 
to  the  nuclear  surface.  Alternatively,  soluble  oligomeric 
subunits might bind to the nuclear envelope and, after satura- 
tion of every available binding site,  in situ polymerization 
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Figure 2. (A) Binding of ~25I-vimentin  to phosphate-extracted nuclear membranes (,x), nuclear membranes before extraction (o), and tryp- 
sinized nuclear membranes (e). (B) Scatchard plotting of the data shown in A (the last point of the isotherm is omitted). (C) Binding 
of ~25I-vimentin  to extracted plasma membrane (e), trypsinized plasma membranes (o), or intact erythrocytes (O). The milligram equiva- 
lent was estimated assuming 10  -6 ~tg of membrane protein/cell as calculated from ghost electrophorograms. This value is similar in the 
order of magnitude with the one calculated for Dogde ghosts of human RBC. (D) Scatchard plotting of the data shown in C. For details 
see Materials and Methods. 
may be accomplished by the addition of more subunits to 
vimentin-receptor complexes. 
In principle, the data shown in Fig. 2 A rule out the first 
possibility because the change in the slope of the isotherm, 
after the pseudo-plateau, is not compatible with a process of 
binding preformed and increasingly larger polymers to the 
nuclear envelopes. If the latter were the case, the measure- 
ments should have yielded a straight line, starting either from 
the very beginning (no critical assembly concentration), or 
following a segment of no or very low binding (if assembly 
of IF does proceed when a critical subunit concentration is 
exceeded). Nevertheless, to better differentiate between the 
previously mentioned scenarios a permutation of the stan- 
dard assay was used: After allowing t25I-vimentin to interact 
with the nuclear membranes, the nonbound probe, remain- 
ing in each assay supernatant, was subjected to ultracentrifu- 
gation and separated into a soluble and a polymeric fraction. 
This analysis revealed that the weight concentrations of  poly- 
meric vimentin that assembled in solution did not parallel the 
linear increase of bound vimentin seen after raising the con- 
centration of the  total  ~25I-vimentin (Fig.  6).  Instead,  the 
levels of  this fraction remained rather constant (within a con- 
centration range of total vimentin at which visible filaments 
of increasing length were detected on the surface of the enve- 
lopes). These experiments favored previous kinetic interpre- 
tations,  showing that newly synthesized vimentin of chick 
embryo erythrocytes is rapidly incorporated into a  soluble 
pool  consisting  of oligomers  and  then  into  an  insoluble 
cytoskeletal fraction (3). 
Furthermore, by assessing the binding of exogenous ~25I- 
vimentin to nuclear envelope preparations containing endog- 
enous vimentin (Fig. 2 A) or intact nuclei (not shown), we 
discovered that these isolates exhibit both a reduced binding 
capacity and a lower affinity for the radiolabeled tracer. Al- 
though the capacity difference is only phenomenal and could 
be  cancelled by considering that  the  vimentin-containing 
membranes are less enriched in authentic envelope polypep- 
tides (three times less lamins as deduced by dye-extraction 
and spectrophotometry of Coomassie Blue-stained gels) and 
more contaminated by histones on a milligram/milligram ba- 
sis,  the  affinity difference between vimentin-depleted and 
nondepleted envelopes remains  substantial  even after this 
correction (as judged by the relative slopes of the isotherms 
in  Fig.  2  A).  Hence,  the data  suggested that the primary 
vimentin-nuclear receptor association is stronger than the 
(subsequent) binding of vimentin molecules to vimentin- 
receptor complexes. 
The same conclusion could be reached by evaluating the 
measurements shown in Fig. 7. In these experiments an ex- 
cess of unlabeled vimentin (or BSA as a control) was used 
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nuclear envelopes. (c) Vimentin-depleted plasma membranes incubated with 400 ~tg/ml of lens vimentin. (d) Nuclear envelopes and 150 
I.tg/ml of vimentin. (e) The same as d with 200 gg/ml vimentin. (f) The same as above with 400 Itg/ml vimentin. (g) The same as above 
with 400  gg/ml vimentin.  Bars, 0.5  gm. 
to displace a standard amount of ~25I-vimentin bound to the 
nuclear  envelopes.  The  apparent Ki calculated  from such 
assays (as the vimentin concentration needed to achieve 50% 
displacement of the tracer) is higher than one expects on the 
basis of the Kd calculated  from the  initial  segment of the 
isotherm shown in Fig.  2 A, or from the saturable binding 
of a vimentin peptide to the nuclear envelopes (see below). 
This difference can only be explained by assuming that the 
exchange of receptor-associated vimentin (high affinity) is 
coupled  with  the  subsequent  rebinding  of displaced  ~25I- 
vimentin to receptor-vimentin complexes (low affinity). 
Site Specificity 
Limited chymotryptic cleavage of IF protofilament units is 
known  to  generate  basically two proteolytic  fragments:  a 
38-40-kD middle piece,  comprising the  a-helical rod do- 
main of the IF subunit molecule, and a  short tail segment 
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vimentin, the first 70-75 amino acid residues that constitute 
the amino-terminal head domain are largely cut into very 
small peptides because of the numerous, exposed (cleavage) 
sites occurring at this 13-sheet folded part of the molecule (9, 
26,  32). 
Therefore, to examine the site specificity of the observed 
interactions,  ~25I-vimentin was digested with chymotrypsin 
and the resulting peptides were combined with plasma mem- 
branes or nuclear envelopes and tested for binding. As shown 
in Fig. 8 A the 6.6-kD carboxy-terminal tail of vimentin could 
associate with the nuclear envelopes, while the 38-kD or-hel- 
ical fragment could not. In agreement also with our previous 
observations (12) neither of these two domains bound to the 
plasma membranes, suggesting that vimentin attaches to the 
plasma membrane skeleton through its amino-terminal head 
domain. A third peptide present in the chymotryptic digest 
could also bind to the nuclear envelopes. This fragment may 
represent a  cleavage intermediate containing the carboxy- 
terminal half of  the middle domain plus the carboxy-terminal 
tail domain of vimentin (Fig.  8 A). 
To quantitate the binding of the vimentin tail fragment to 
the nuclear envelopes, increasing amounts of the digest were 
incubated with the appropriate membranes and the radioac- 
tivity associated with the 6.6-kD band was measured by ex- 
cising appropriate bands from the gels.  An isotherm con- 
structed from such assays is shown in Fig. 8 B. The binding 
of the fragment was saturable, as expected, because of the 
inability of the cleaved peptide to polymerize. The Ka of 
this interaction (estimated from the relative concentrations 
needed for 50%  saturation) was in the order of 1.4  ×  107 
M-'. Interestingly, Scatchard plotting of the data (Fig. 8 C) 
Figure 4.  (a) Ankyrin content of red blood cell membranes as de- 
tected by immunoblotting with anti-ankyrin antibodies. Lane 1, nu- 
clear envelopes (extracted); lane 2, plasma membranes (extracted). 
An autoradiogram is shown. For details see Materials and Methods. 
The position of ankyrin is indicated by an arrow. The nature of the 
low molecular weight products is not known but these bands most 
probably represent proteolytic fragments of the same polypeptide. 
(b) Effect of anti-ankyrin antibodies on the binding of mI-vimen- 
tin to (extracted) plasma membranes. The membranes (0.2 mg/ml) 
were preineubated for 1 h with the indicated dilutions of immune 
(e) or nonimmune (A) sera. '2~I-Vimentin  (4 gg/ml, 216,000 cpm/ 
~tg) was incubated as in the standard binding assays described in 
Materials and Methods.  100% binding signifies samples that re- 
ceived no antibodies. 
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Figure 5. (a) Time course of the binding of 125I-vimentin to nuclear 
envelopes. 6 ~tg of ~25I-vimentin was incubated with nuclear enve- 
lopes as specified  in Materials  and Methods for the time periods 
indicated on the abscissa.  The centrifugation  time was not consid- 
ered for constructing the curve. (b) Salt dependence of the binding 
of 125I-vimentin to nuclear envelopes. Experiments  were executed 
as in a in a buffer containing  5 mM NaPO4,  0.1 mM PMSF,  and 
2  mM MgC12 pH 7.6 plus  the indicated  concentrations  of NaC1. 
The maximum binding  achieved  was considered  100% binding. 
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Figure 6.  Centrifugational analysis  of the nonbound fraction of 
~25I-vimentin. The binding assay was executed as described in Ma- 
terials and Methods and then, after the nuclear membranes were 
pelleted, the supernatants were collected and centrifuged at 100,000 g 
for 30 min (4°C).  Radioactivity associated with the pellet or the 
supernatant of this  centrifugation was measured and  the weight 
concentrations  of  soluble  (o),  polymeric  (A),  or  bound  (e) 
~25I-vimentin were plotted as a function of the total vimentin con- 
centration in the original assay mixture. 
generated, again, a convex curve, indicating that the primary 
vimentin tail domain-envelope interaction was of a positive 
cooperative character. 
Discussion 
Segregated and Distinct Attachment Sites for IF 
The data presented here demonstrate the occurrence of two 
distinct  vimentin  receptor  systems  segregated  respectively 
into the nuclear envelope and the plasma membrane of avian 
erythrocytes. Quantitative binding assays, involving purified 
lens  125I-vimentin  and  vimentin-depleted  membrane  frac- 
Table L  Vimentin-binding  Capacities of  Membrane Preparations after Various Treatments 
Membranes  Treatment  Binding of t-'~I-vimentin  DNA/protein 
Nuclear envelopes 
Nuclear envelopes 
Nuclear envelopes 
Nuclear envelopes 
Nuclear envelopes 
Plasma membranes 
Plasma membranes 
Plasma membranes 
Extraction with 10 mM NaPO4 
RNAase/DNase digestion 
Extracted with 0.17  M  acetic acid 
Extracted with 10 mM NaPO4, 
heated at 65°C for 2 min 
Extracted with distilled water 
Extracted with 0.17 M  acetic acid 
Extracted with 10 mM NaPO4, 
heated at 65°C for 2  rain 
%  ug/ug 
19  _+  0.1  0.44 
100  0.11 
100  ___  0.3  0.08 
0.2  +  0.0  ND 
120  _+  0.0  ND 
100  0.03 
7.8  ~  1.2  ND 
40  +  1.0  ND 
The assays were executed as specified in Fig. 5. The extractions of the membranes were as described in Materials and Methods. ND, Not determined. 
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Figure 7. Displacement of bound t25I-vimentin  by an excess of un- 
labeled vimentin,  (o); vimentin,  (o); BSA, (control).  The assays 
were executed as defined in Materials and Methods,  with  12.7 lag 
of t25I-vimentin (1,574 cpm/lag). 
tions, indicated that vimentin interacts in a cooperative and 
nonsaturable fashion with the nuclear envelope, while under 
similar conditions,  it associates saturably and noncoopera- 
tively with the plasma membrane. When analyzed by elec- 
tron microscopy, the nonsaturable binding corresponds to an 
extensive polymerization of the envelope-associated vimen- 
tin in situ, whereas the saturable binding seems to reflect the 
fact that such an assembly could not take place onto a sub- 
strate like the plasma membrane. Thus,  it is likely that the 
different quantitative parameters deduced  by assessing the 
binding  of labeled  vimentin to each membrane species in 
vitro are genuine manifestations of two distinct attachment 
mechanisms. 
After proteolytic cleavage of vimentin molecules (whereby 
their head domains are largely destroyed and their polymer- 
ization potential is lost) (19, 25,  32), their carboxy-terminal 
tail domains retain the ability to bind to the nuclear envelopes 
but not to the plasma membranes. This binding now shows 
saturability. Conversely, the a-helical, central domains fail 
to associate with either membranes. These data, in combina- 
tion with previous studies (12),  suggest that the site-specific 
recognition of the vimentin molecules by distinct and spa- 
tially separated receptors may be the principle underlying 
the differential mode of attachment of vimentin to the mem- 
branes. 
As  was  previously  stated  (11), we  have been  unable  to 
detect  any  interactions  between  vimentin  and  membrane 
phospholipids as it has been claimed by others (27, 33). Pro- 
teolyzed nuclear envelopes and plasma membranes, or acid- 
treated preparations, bound negligible amounts of the vimen- 
tin  tracer  (Table  I),  whereas  detergent-extracted  nuclear 
membranes were not affected (see companion paper). There- 
fore, we believe that the reported binding of isolated vimen- 
tin to purified phospholipids may be either irrelevant to the 
interactions  studied here or,  most likely, a  reflection of an 
electrostatic association between the basic head domains of 
vimentin and  some phosphate  moieties  occurring  in  pro- 
teins,  lipids,  and  nucleic  acids.  However, how and  where 
Figure 8. (A) Site specificity in vimentin-membrane interactions. A ~25I-vimentin  chyrnotryptic digest, prepared as described  (58 lag/ml 
vimentin,  1,700 cpm/lag) was co-incubated with plasma membranes (40 I.tg)  or nuclear envelopes (70 lag) under standard conditions (assay 
volume 180 ILl). The resultant pellets and supernates were subjected to electrophoresis  in 15 % acrylamide gels and autoradiographed. 
M, plasma membranes.  E, nuclear envelopes. E  pellet. S, supernatant.  Arrow indicates the 38-kD middle domain of vimentin and the 
arrowhead,  its 6.6-kD domain (photographed in reverse contrast).  The relatively heavier labeling of the tail piece is due to the higher 
accessibility of  this peripheral domain to the Bolton-Hunter reagent when concentratext  vimentin samples are used. Under these conditions 
the protein partially assembles during iodination and the coiled-coil regions are apparently protected. With more dilute preparations the 
labeling is proportional  to the number of iodination sites occurring  at the 38- and the 6.6-kD domains (more in the former and mainly 
Lys or His).  (B) The binding of the 6.6-kD tailpiece to nuclear envelopes. Assays were executed as in A with increasing quantities of 
the digest. After electrophoresis the appropriate bands were excised and the radioactivity was determined by ),-counting. (C) The same 
data shown in B after Scatchard analysis. 
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along the membranes remains to be investigated. 
The apparent heterogeneity in the vimentin receptor sites 
occurring at the plasma membrane of  avian erythrocytes may 
be morphogenetically significant. Although the existence of 
two different receptors would not influence the direction of 
IF assembly (since both seem to have the same site-speci- 
ficity for vimentin), the observed differences in the relative 
affinities for vimentin may provide a basis for establishing 
assymetric IF skeletons during development. Therefore, it 
would be interesting to fully characterize these attachment 
proteins and study their expression and partitioning during 
the various phases of erythroid development. 
Vectorial Assembly 
The above findings support previous morphological observa- 
tions, indicating that the assembly of 10-nm filaments may 
occur vectoriaUy, that is, from the nucleus towards the cell 
surface. As early as 1971, Franke, studying the structural as- 
sociations of cytoplasmic filaments with the nuclear enve- 
lope, postulated that "the formation of such tubules and fila- 
ments is nucleated at cytomembraneous surfaces" (7). Later, 
Granger and Lazarides (14) noticed that chick embryonic 
erythrocytes  possessed relatively few vimentin filaments that 
were associated with the nucleus but,  in general, did not 
reach the cellular periphery. In contrast, more developed red 
cell forms contained numerous filaments, extending from the 
nuclear periphery to the plasma membrane. This suggests 
that 10-nm filaments may grow unidirectionally. In addition, 
Wang (34) reported that vimentin fibers could be assembled 
from intact nuclei of tissue culture ceils after an incubation 
with purified vimentin. Therefore, it seems reasonable to in- 
fer that the initiation of IF assembly may occur in the neigh- 
borhood of the nuclear envelope. 
Although a  vectorial assembly route explains better the 
data obtained by binding studies, it does not necessarily im- 
ply the existence of two separate receptor systems with dis- 
tinct site  specificities.  Indeed,  a  preferential IF assembly 
from the nucleus would be theoretically possible if the recep- 
tor concentrations were vastly greater at the nuclear envelope 
than in the plasma membrane, even if the binding sites were 
structurally identical in both cases. Alternatively, the recep- 
tors could have been structurally different, but functionally 
similar, recognizing the same vimentin domain, albeit to a 
different degree (different affinities). The latter possibility is 
an attractive one since current models for IF organization fa- 
vor a structural apolarity of these assemblies. That the two 
dimeric pairs in each protofilament assume an anti-parallel 
orientation could be thought to result in linear polymers with 
identical  ends  (8,  10). Hence,  it  is  conceivable that  the 
membrane-bound vimentin receptors could recognize more 
or less the same molecular features on the polymer ends. 
Our present data argue against these possibilities as clear- 
cut differences could be detected, not only in the capacities 
and affinities of the vimentin-membrane interactions,  but 
also in the site specificities involved and the structural char- 
acteristics of  the vimentin receptors (see companion article). 
Knowing that, one is allowed to reverse the question: Do na- 
tive IFs,  inside eukaryotic cells,  show the same structural 
apolarity with the in vitro reconstituted assemblies, or differ 
from them in a fundamental manner? 
A Model for a Receptor-modulated Assembly oflFs 
Newly made vimentin subunits inside eukaryotic cells, im- 
mediately after biosynthesis, would conceivably face one of 
the following fates: they would either polymerize spontane- 
ously forming free-floating cytoplasmic filaments,  or they 
would bind as lower oligomers (i.e., tetramers, see reference 
31)  to  membrane-associated  receptors.  Naturally,  such  a 
choice of binding will depend on the relative affinities in- 
volved.  The first possibility is  not favored by data  accu- 
mulated from in vitro studies, since vimentin-vimentin as- 
sociations  seem  weaker  than  nuclear  envelope-vimentin 
interactions  (this  report).  Conversely,  vimentin-plasma 
membrane interactions appear to be of the same order of 
magnitude  as  the  vimentin-vimentin  self-association that 
leads to IF elongation (11, 12,  and this report). Thus, one 
could predict that, at first, most of  the newly synthesized ma- 
terial would be sequestered around the nucleus. Based on the 
cooperative binding of the vimentin tail peptide to its nuclear 
receptor, it is reasonable to assume also that a primary nu- 
cleus of IFs may be assembled in situ onto the nuclear enve- 
lope. Then, a gradient of affinities as described above, i.e., 
vimentin-vimentin binding weaker than vimentin binding to 
vimentin-nuclear receptor complexes and this weaker than 
vimentin-nuclear receptor binding, may dictate a vectorial 
assembly of IF units towards the cell surface. 
Elongation of such units could be subsequently achieved 
when a certain subunit concentration value is exceeded in the 
cytoplasm and plasma membrane anchorage may occur as 
the filaments increase in length. Finally, termination of fur- 
ther polymerization could be the result of a specific blockade 
(capping) of  filament ends imposed after connecting IF to the 
plasma membrane skeleton (12). 
This model, of course, which is mainly based on affinity 
considerations, could be influenced by other parameters such 
as the relative numbers of attachment sites for IFs expressed 
at a given developmental stage along the major membranes. 
It might also be modified if indeed various posttranslational 
modifications of IF subunits affect their functional proper- 
ties. However, since the expression of ankyrin seems to be 
constitutive during erythropoesis and since the phosphoryla- 
tion of vimentin does not directly relate with its polymeriza- 
tion state (31), we believe that the scenario described above 
constitutes the most likely assembly pathway,  provided that 
we can extrapolate from in vitro data to in vivo operating 
principles. 
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